May 19th, 2015

JanssenAWorldFreeFrom

Janssen Recognizes World IBD Day

By Scott Plevy, M.D., Disease Area Stronghold Leader, Inflammatory Bowel Disease (IBD), and Sean Larkin, Disease Area Stronghold Commercial Leader, IBD, Janssen

 Today, May 19th, the Janssen Pharmaceutical Companies of Johnson & Johnson recognize World Inflammatory Bowel Disease (IBD) Day, an annual event to raise awareness and support the five million people living with Crohn’s disease and ulcerative colitis (UC).

At Janssen, we work each and every day to improve the lives of people living with Crohn’s disease and UC—a passion that’s inspired us for more than two decades.

Guided by the conviction that there are no limits to science, we recognize that, despite our successes, we can do more for patients. As innovators and collaborators, we are committed to treating, intercepting and, one day, curing IBD.

We hope that you support World IBD Day and join the conversation on Twitter and LinkedIn by sharing what a world free from IBD means to you using #aworldfreefrom.


ScottPlevyJNJScott Plevy, M.D., is Vice President, Disease Area Stronghold Leader, IBD, Immunology Therapeutic Area, Janssen Research & Development, LLC.

 

 

Sean Larkin - Immunology - Comm DAS Lead_jpgSean Larkin is Vice President, Disease Area Stronghold Commercial Leader, Pulmonary and IBD, Janssen Global Services, LLC.

Read More

May 15th, 2015

Johnson & Johnson Employees Honored by Operation Smile

Would you ever think that polishing shoes could make a life-changing difference for someone you’ve never met? Or playing chess? Or selling ice cream?

Johnson & Johnson employees have changed more than 100,000 children’s lives doing things just like those to raise money to benefit Operation Smile. And last night I had the tremendous privilege of representing our employees to accept the first-ever Global Impact Award from Operation Smile. This honor recognizes the many hours and boundless passion that our employees have brought to fundraising activities, volunteer projects and other initiatives to benefit Operation Smile and the children it serves.

In my 30+ years with Johnson & Johnson, I have never seen our employees so engaged in our shared effort to serve patients all over the world. Fulfilling our Johnson & Johnson Credo is a mission we all hold near and dear to our hearts. By supporting Operation Smile in its mission to provide safe surgical solutions to children born with cleft lip or cleft palate, they bring to life our Credo responsibility to our patients.

Every three minutes, a child enters the world with this deformity. Without treatment, these children may not get enough to eat. They often have speech problems.

Read More

May 14th, 2015

Q&A with J&J Human Performance Institute’s Jennifer Lea

Editor’s Note: Johnson & Johnson is a proud sponsor of the Know Your Value tour, a nationwide effort focused on empowering women to express their worth in business and in life. Part of the tour includes the Grow Your Value contest hosted by best-selling author and Morning Joe co-anchor Mika Brzezinski. At the Center of the Contest is the Johnson & Johnson Human Performance Institute, which works with the finalists to help transform their lives through coaching, networking and support. J&J recently spoke with HPI Performance Coach Jennifer Lea about coaching women to recognize their value and the important role of energy management.

Jennifer Lea Joanna Schwartz Grow Your Value

Jennifer Lea (right) with Joanna Schwartz, winner of the Grow Your Value contest in Philadelphia.

Q: How is the Johnson & Johnson Human Performance Institute playing a role in teaching women to know their value?

A: The Johnson & Johnson Human Performance Institute is the pioneer in training business leaders to achieve sustained high performance by expanding and managing their energy. We’ve developed life-changing programs that take a holistic, mind and body approach to help individuals achieve their best at work and at home by making fundamental life changes. Our renowned Corporate Athlete Program helps people become physically energized, emotionally connected, mentally focused, and completely aligned with achieving their personal mission so they can achieve their personal best both at work and at home.

Read More

May 10th, 2015

Leadership Lessons from Mom

By Alex Gorsky, Chairman and CEO, Johnson & Johnson

Mother'sDayPost

Today is Mother’s Day here in the United States and in many countries around the globe. Since my mom passed away a few years ago, the holiday has become a little bittersweet. But the day has always reminded me how fortunate I am to have had a mom who gave me the tools I needed to succeed in life and also in business.

My mom didn’t have an MBA or work in corporate America, but she very well could have given the abundance of leadership lessons she dispensed to my five siblings and me during our upbringing in the Midwest.

Though dad was a two-star general in the Army Reserves, Mom was the true general when it came to the six Gorsky kids. She definitely adhered to the proverb that if you give a man a fish, you feed him for a day; teach him to fish, and you feed him for a lifetime. Rather than doing everything for us, mom instead taught us how to do things for ourselves.

From a young age, I was expected to do my part around the house. When my clothes were dirty, I did the wash.

Read More

May 8th, 2015

Innovating New Approaches for Compassionate Use Requests

By Joanne Waldstreicher, Chief Medical Officer, Johnson & Johnson and Amrit Ray, Chief Medical Officer, Janssen Pharmaceutical Companies of Johnson & Johnson

Patients with serious illnesses and their families who have run out of treatment options and do not qualify for clinical trials need to know that their requests for compassionate access to investigational medicines have been treated in as thoughtful and objective manner as possible. We understand the importance of making medicines available to people in urgent need, and have worked in the past to try to grant pre-approval access to medicines when appropriate for patients with no other treatment options. These decisions present some of the most difficult challenges for many reasons, including the limited information on safety and efficacy we often have early in development, and since supplies of investigational medicines are often limited while they are still being developed. With such important decisions, we believe that there is a continued need to ensure that we are as objective and as thoughtful as possible. As physicians, it is inspiring to see innovation in science offering such great potential for patients.

As an extension of Johnson & Johnson’s (J&J) long-standing commitment to the highest standards of scientific and ethical decision-making, we are announcing a first of its kind partnership between J&J and the New York University School of Medicine to obtain independent review of individual compassionate use requests for access to investigational medicines.

Read More

May 6th, 2015

J&J CEO Gorsky Thanks Nurses in Huffington Post Op-Ed

In honor of National Nurses Week, Johnson & Johnson Chairman and CEO Alex Gorsky wrote a column for the Huffington Post about the ongoing shortage of nurses in the United States.

“Nurses are true superheroes,” he says, “working to meet society’s greatest challenge — health care. National Nurses Week (May 6-12) allows our nation to officially recognize these incredible individuals and say thank you.”

Please read Alex’s blog on the Huffington Post

Read More

May 4th, 2015

Janssen Recognizes World Asthma Day

By Liza O’Dowd, M.D., Disease Area Stronghold and Development Leader, Pulmonary, and Sean Larkin, Disease Area Stronghold Commercial Leader, Pulmonary, Janssen

Today, May 5th, Janssen Research & Development proudly joins the Global Initiative for Asthma (GINA) to recognize World Asthma Day, an annual event to raise awareness, improve care and generate support for the more than 300 million people worldwide who are living with this potentially life-threatening disease.

At Janssen, we are building a deep scientific understanding of asthma to change the way we study, treat and one day intercept the disease. Our team of internal pulmonary experts and external collaborators are working together every day toward a better, healthier tomorrow.

We want to know asthma personally—how it affects people in different ways, how tailored therapies can be developed for individuals and how the work we’re doing will impact the global community. You can learn more about our vision for the future from the video below.

Together, we can raise awareness of this life-altering disease and show our commitment to creating a world free from asthma. Join the conversation on Twitter and LinkedIn by sharing your thoughts on what a world free from asthma means to you using #aworldfreefrom.

Read More

April 30th, 2015

2014 Dr. Paul Janssen Award Winners Continue to Make an Impact, Named to TIME’s 100 Most Influential List

By Seema Kumar, Vice President of Innovation, Global Health and Policy Communication, Johnson & Johnson

Annually, TIME magazine publishes a list of The 100 Most Influential People in the World, recognizing pioneers, titans, artists, leaders, and icons for their influence and contributions during the prior year. Earlier this month, TIME unveiled its 12th annual list, which included the winners of the 2014 Dr. Paul Jansen Award for Biomedical Research, Drs. Emmanuelle Charpentier and Jennifer Doudna. We were thrilled to see last year’s Award winners recognized on this prestigious list!

Dr. Paul Janssen Award Winners

L to R: Chief Scientific Officer Dr. Paul Stoffels, Drs. Emmanuelle Charpentier and Jennifer Doudna, Chairman and CEO Alex Gorsky

Johnson & Johnson honored Drs. Charpentier and Doudna last year for their discovery of the CRISPR-Cas9 method of genetic editing, considered one of the most significant breakthroughs in molecular biology in the past decade. This new DNA editing strategy has led to a substantial leap in scientists’ ability to manipulate genetic processes and holds promise for significantly advancing drug development. As Johnson & Johnson Chief Scientific Officer Paul Stoffels said, “The work of Drs. Charpentier and Doudna has the potential to make a significant impact on human health, which is the very heart of Dr.

Read More

April 29th, 2015

J&J and the 21st Century Working Family

By Peter Fasolo, Vice President, Worldwide Human Resources and Lisa Blair Davis, Vice President, International Total Reward and Global Benefits

At Johnson & Johnson, we are firmly committed to living Our Credo. A key tenet of this is to respect the dignity of our employees, foster a workplace culture of health and provide equal opportunity for everyone. This focus on diversity and inclusion makes us a more caring company, and enables our people to truly come together to solve the world’s most pressing healthcare challenges.

To that end, we are thrilled about the announcement we made this morning: a significant upgrade to our parental leave policy in the United States. Starting May 1st, all new parents – maternal, paternal, and adoptive – will have the opportunity to take eight additional weeks of paid leave during the first year of the family’s birth or adoption.

JNJParentalLeaveThis new policy is in addition to our current leave policies, which means moms who give birth can take up to 17 paid weeks off. The time doesn’t need to be taken consecutively, so our people can enjoy some much-needed flexibility during such a critical time in their lives. We’re also making it retroactive for employees who became parents on or after May 2014.

Read More

April 23rd, 2015

Voting Results from Johnson & Johnson’s Annual Meeting of Shareholders

By Doug Chia, Assistant General Counsel & Corporate Secretary, Johnson & Johnson

April 23rd, 2015 – Today, Johnson & Johnson held its 127th Annual Meeting of Shareholders in New Brunswick, NJ, returning to the State Theatre, where our Annual Meeting was held back in 1989. (Our Kilmer House blog has a nice piece about the history of the Johnson & Johnson Annual Meeting.)

Here is a recap of the official business from today’s meeting, including preliminary voting results:

1) Election of Directors: All 11 Director nominees were elected to serve one-year terms on the Board of Directors with the support of over 95 percent of the votes cast.  Alex Gorsky (Chairman/CEO) received the support of 96.6 percent.  A full list of our Board members, including their biographies, can be found in the Corporate Governance section of the investor.jnj.com website.

2) Advisory Vote to Approve Named Executive Officer Compensation: In this advisory vote, our shareholders approved the company’s executive compensation philosophy, policies and procedures and the compensation of the executive officers named in the 2015 Proxy Statement with the support of 95.1 percent of the votes cast.

3) Ratification of Appointment of Independent Registered Public Accounting Firm: Our shareholders approved the appointment of PricewaterhouseCoopers LLP to serve as our independent auditors for fiscal 2015 with the support of 98.8 percent of the votes cast.

Read More